ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
36.26
0.00%
US Tech 100
19,887.20
0.21%
S&P 500
5,631.22
0.28%
US Dollar vs CAD
1.3683
0.03%
Bitcoin
63,651.36
-1.85%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. ImmunoGen Inc (IMGN)

  7. ImmunoGen Inc (IMGN) News

IMGN

ImmunoGen (IMGN)

ImmunoGen Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IMGN
DateTimeSourceHeadlineSymbolCompany
05/02/20223:30PMBusiness WireImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:IMGNImmunoGen Inc
04/21/20223:01PMBusiness WireImmunoGen Announces Conference Call to Discuss Its First Quarter 2022 Operating ResultsNASDAQ:IMGNImmunoGen Inc
04/20/20224:39PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:IMGNImmunoGen Inc
04/13/20224:08PMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:IMGNImmunoGen Inc
04/04/20223:31PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:IMGNImmunoGen Inc
04/04/20223:13PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
04/04/20223:13PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
04/01/20223:30PMBusiness WireImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:IMGNImmunoGen Inc
03/31/20223:30PMBusiness WireImmunoGen Announces Webcast of Panel Discussion at Upcoming Canaccord Genuity Horizons in Oncology Virtual ConferenceNASDAQ:IMGNImmunoGen Inc
03/29/20225:30AMBusiness WireImmunoGen Submits Biologics License Application to the US Food and Drug Administration for Mirvetuximab Soravtansine in Ovarian CancerNASDAQ:IMGNImmunoGen Inc
03/28/20228:35AMTipRanksBMO Capital Thinks ImmunoGen’s Stock is Going to RecoverNASDAQ:IMGNImmunoGen Inc
03/22/20228:35AMTipRanksBMO Capital Thinks ImmunoGen’s Stock is Going to RecoverNASDAQ:IMGNImmunoGen Inc
03/22/20227:05AMTipRanksImmunoGen (IMGN) Gets a Hold Rating from J.P. MorganNASDAQ:IMGNImmunoGen Inc
03/21/202210:05AMTipRanksAnalysts’ Opinions Are Mixed on These Healthcare Stocks: ImmunoGen (IMGN) and Decibel Therapeutics (DBTX)NASDAQ:IMGNImmunoGen Inc
03/21/20227:46AMTipRanksJefferies Thinks ImmunoGen’s Stock is Going to RecoverNASDAQ:IMGNImmunoGen Inc
03/21/20225:26AMTipRanksH.C. Wainwright Maintains a Buy Rating on ImmunoGen (IMGN)NASDAQ:IMGNImmunoGen Inc
03/19/20226:15PMBusiness WireImmunoGen Presents Full Results from Positive Pivotal SORAYA Trial of Mirvetuximab Soravtansine in Ovarian Cancer at SGO Annual MeetingNASDAQ:IMGNImmunoGen Inc
03/14/20228:45AMTipRanksAnalysts Offer Insights on Healthcare Companies: Evelo Biosciences (EVLO) and ImmunoGen (IMGN)NASDAQ:IMGNImmunoGen Inc
03/11/20221:15PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IMGNImmunoGen Inc
03/10/20225:30AMBusiness WireImmunoGen to Present Full Results from SORAYA Trial of Mirvetuximab Soravtansine in Ovarian Cancer at the Society of Gynecologic Oncology Annual MeetingNASDAQ:IMGNImmunoGen Inc
03/01/20223:30PMBusiness WireImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:IMGNImmunoGen Inc
02/28/20224:36PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:IMGNImmunoGen Inc
02/25/20226:14AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
02/25/20225:30AMBusiness WireImmunoGen Reports Recent Progress and 2021 Financial ResultsNASDAQ:IMGNImmunoGen Inc
02/23/20223:30PMBusiness WireImmunoGen Announces Webcast of Panel Discussion at Upcoming Cowen 42nd Annual Health Care ConferenceNASDAQ:IMGNImmunoGen Inc
02/15/20225:30AMBusiness WireImmunoGen Announces a Global, Multi-Target License Agreement of its Novel Camptothecin ADC Platform to Lilly for Up to $1.7 BillionNASDAQ:IMGNImmunoGen Inc
02/14/20225:19PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IMGNImmunoGen Inc
02/10/20223:01PMBusiness WireImmunoGen Announces Conference Call to Discuss Its 2021 Operating ResultsNASDAQ:IMGNImmunoGen Inc
02/10/20227:33AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IMGNImmunoGen Inc
02/09/20228:23AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IMGNImmunoGen Inc
 Showing the most relevant articles for your search:NASDAQ:IMGN

Your Recent History

USOTC
AXXA
Exxe (PK)
USOTC
MGON
Megola (PK)
NASDAQ
FFIE
Faraday Future Intellige...
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
USOTC
IQST
iQSTEL (QX)
USOTC
RONN
Ronn Motor (PK)
USOTC
FNMA
Fannie Mae (QB)
USOTC
BLEG
Branded Legacy (PK)
USOTC
WDLF
Decentral Life (PK)
USOTC
GRST
Ethema Health (PK)
USOTC
UBQU
Ubiquitech Software (PK)
USOTC
ENZC
Enzolytics (PK)
USOTC
RNVA
Rennova Health (PK)
USOTC
TPTW
TPT Global Tech (PK)
USOTC
HIRU
Hiru (PK)
USOTC
IFUS
Impact Fusion (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved